TY - GEN 
AU - REMAP-CAP Writing Committee for the REMAP-CAP Investigators
PY - 2022
UR - http://hdl.handle.net/10818/54595
AB - Importance  The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is uncertain.  Objective  To determine whether antiplatelet therapy improves outcomes for critically ill adults with COVID-19.  Design, Setting, and Participants...
LA - eng
PB - JAMA
KW - Question
KW - Findings
KW - Meaning
TI - Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19:  A Randomized Clinical Trial
DO - 10.1001/jama.2022.2910
ER -